E. Dotor
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Colorectal and Anal Carcinomas, Colorectal Cancer Surgical Treatments, Genetic factors in colorectal cancer
Most-Cited Works
- → microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers(2013)162 cited
- → Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment(2006)125 cited
- → A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer(2006)70 cited
- → First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours(2015)56 cited
- → SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)(2016)39 cited
- → Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study(2018)27 cited
- → The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity(2007)24 cited
- → First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)(2019)17 cited
- → 1.a Reunión Nacional de Trabajo Multidisciplinar en Oncogeriatría: documento de consenso(2012)15 cited
- → Extravasation of oxaliplatin: an infrequent and irritant toxicity(2009)14 cited